Interstitial high‐dose‐rate brachytherapy combined with cervical dissection on head and neck cancer

Abstract

These results suggest that I-HDR can be recommended in selected patients with first presentation lesions, local recurrences, or second primary carcinomas, even with a previous course of EBRT, but further studies are eagerly awaited to delineate the optimum schedule for this combination-treatment modality.